Stockreport

Travere Therapeutics Reports First Quarter 2024 Financial Results [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF Received 511 new patient start forms (PSFs) for FILSPARI in Q1 2024; Total of 1,963 PSFs received since launch Net product sales of FILSPARI totaled $19.8 million for [Read more]